Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

NEMUS Activities 2016

NEMUS Activities 2016



Estimadas y estimados colegas:

 

Reciban un saludo por el inicio de este año 2017, cuyo primer mes ha pasado muy rápidamente​. ​Son tiempos en que las discusiones sobre la implementación de PrEP van haciéndose más frecuentes y sostenidas en la región, con planes ​​crecientes de estudios complementarios que permitan obtener mayor evidencia para decidir su inclusión en la respuesta programática, o para adaptarlo al sistema de salud de países determinados. Por ello, ​continuaremos con la presentación de experiencias de interés, o resultados de investigaciones relevantes. En ese sentido, ​el proximo jueves​ ​2 de Febrero,​​ el Dr.​ ​Hamid Vega y el ​Lic. Steven Díaz de las Clinicas Especializadas Condesa-Iztapalapa de la Ciudad de México,​ nos presentará​​n:

 

"Situación y Perspectivas del Acceso a PrEP para la Prevención del VIH en México"

 

Hamid Vega

Hamid Vega es médico psiquiatra egresado del Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”. Doctorante en Salud Mental Pública por la UNAM. Coordinador del Programa de Salud Mental de la Clínicas Especializadas Condesa y Condesa-Iztapalapa. Es miembro del Comité Técnico Consultivo sobre VIH e ITS de la OPS. Junto con su equipo, se encargan de la atención clínica e investigación de los trastornos mentales en las personas con VIH y otras minorías sexuales.

 

Steven Diego

Steven Diego estudió Psicología y Matemáticas en la Universidad del Estado de Illinois. También tiene formación en Promoción y Educación en Salud Pública. Tiene más de 30 diplomados en temas de enfermedades infecciosas (incluyendo VIH) en E.U.A. y Latinoamérica. Su experiencia en VIH, tanto en prevención como en provisión de servicios, ha sido desarrollada en Estados Unidos, México, Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panamá, Perú, Ecuador, Brasil, Argentina y Chile. Actualmente es el Subdirector de Prevención e Información para el Centro para la prevención Integral del VIH/sida de la Ciudad de México.

 

El webinar se desarrollará el Jueves 02 de Febrero de 2017 a las ​7​:00 am en Los Angeles, 9:00am en C. de ​México, C. de ​Guatemala, y San José; 10.00am en ​Nueva York, ​Lima​, Bogotá​, Quito​, ​​C. de Panamá​ y Washington​; ​1​2m ​en ​Buenos Aires​ y Santiago​; 1:00pm en ​Rio de Janeiro y ​Brasilia, ​3​:00pm en Lisboa y Londres; y ​4​pm en Madrid y París. Para otros países/ciudades, por favor visite:

 

http://www.worldtimeserver.com/meeting-planner.aspx

 

Para registrarse para el webinar, por favor ingrese en:

 

https://goo.gl/forms/fewkFsAplFqzVbZv1

 

Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

 

 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Dear colleague:

 

On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series: the third On Monday, 5 December, Jerome Galea, PhD, who is in charge of the PrEP in the Wild Study of individual/community led access to PrEP, will present on

PrEP in the Wild - An interim Analysis
(05 December)

Jerome Galea

Jerome Galea is the Deputy Director of Partners in Health and the co-founder of the LGTB Epicenter community center, both organizations in Lima, Peru, and a postdoctoral Fellow at the Harvard Medical School. He has studied and published on the acceptability of PrEP in Peru and is currently investigating the informal use of PrEP in the Wild PrEP study.

To register for the webinar please click on the following link:

 

https://goo.gl/forms/0xsEvSQuFL8BHflE2

 

After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Dear colleague:

 

On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series: the second on Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on 

 

ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
(28 November)

Rafael Landovitz

Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Dear colleague:

 

On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series, the first one On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally:

 

PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
(22 November)

sibil hosek

Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

 

Alejandra Trossero

Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Dear colleague:

 

On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series:

-  On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally: PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study.

-  On Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference.

-  On Monday, 5 December, Jerome Galea, PhD, who is in charge of the PrEP in the Wild Study of individual/community led access to PrEP, will present on PrEP in the Wild - An interim Analysis.


All webinars will take place at 7am (PST), 9am (Mexico City) 10am (EST, Lima, Panama), 12m (Buenos Aires), 1pm (Brasilia, Rio), 3pm (London), 4pm (CST), 5pm (Johannesburg), 10pm (Bangkok), 2am 1 (Sydney). For other locations, please check:

 

http://www.worldtimeserver.com/meeting-planner.aspx

 

PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
(22 November)

sibil hosek

Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

 

Alejandra Trossero

Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

To register for the webinar please click on the following link:

 

https://goo.gl/forms/gHS3HsaflKdvBpU02

 

ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
(28 November)

Rafael Landovitz

Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

To register for the webinar please click on the following link:

 

https://goo.gl/forms/2BxXvMKKGb0AYsKI2

 

PrEP in the Wild - An interim Analysis
(05 December)

Jerome Galea

Jerome Galea is the Deputy Director of Partners in Health and the co-founder of the LGTB Epicenter community center, both organizations in Lima, Peru, and a postdoctoral Fellow at the Harvard Medical School. He has studied and published on the acceptability of PrEP in Peru and is currently investigating the informal use of PrEP in the Wild PrEP study.

To register for the webinar please click on the following link:

 

https://goo.gl/forms/0xsEvSQuFL8BHflE2

 

After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Estimadas y estimados colegas:

 

En una etapa en la cual la región comienza a considerar cada vez más claramente la posibilidad de incluir PrEP en el marco de los esfuerzos de prevención combinada del VIH, resulta de interés conocer las lecciones del Estudio iPrEx OLE que pueden ser de utilidad en dichos esfuerzos. El Estuido iPrEx OLE fue la extensión de etiqueta abierta del estudio iPrEx, realizado en Brasil, Ecuador, Estados Unidos, Perú, Sudáfrica y Tailandia; si bien no fue un estudio demostrativo en servicios públicos de salud, nos puede ofrecer aportes valiosos en una etapa en que otros estudios demostrativos recién están siendo implementados o, incluso, planeados. Por ello, el proximo jueves 3 de Noviembre el Dr. Juan Vicente Guanira nos presentará:

 

"Implementación de PrEP en América Latina: Aportes del Estudio iPrEx OLE"

 

guanira 200

El Dr Juan Guanira es medico graduado en la Universidad Peruana Cayetano Heredia y obtuvo una Maestría en Salud Publica con mención en Epidemiologia en la Universidad de Washington, en Seattle EEUU. Tiene mas de 15 años de experiencia en el campo de la investigación en prevención del VIH. Ha sido investigador de una de las sedes del estudio iPrEx que demostró la eficacia de PrEP en Hombres y sirvió para la aprobación de la indicación de PrEP para Truvada. Actualmente es investigador asociado del Secretariado de NEMUS (Network for Multidisciplinary Studies on ARV-Based Prevetion for HIV). Es también Director Ejecutivo de Investigaciones Médicas en Salud (INMENSA), una ONG dedicada a la investigación, prevención y atención del VIH en Lima, Peru.

 

 

El webinar se desarrollará el Miercoles 03 de Noviembre de 2016 a las 8:00 am en Los Angeles, 9:00am en C. de Guatemala, y San José; 10.00am en Ciudad de México, Bogotá, Lima, Quito y Ciudad de Panamá; 11:00am en Santo Domingo, Washington, La Paz, La Habana y Santiago; 12:00m en Brasilia y Buenos Aires; 4:00pm en Lisboa y Londres; y 5pm en Madrid y París. Para otros países/ciudades, por favor visite:

 

http://www.worldtimeserver.com/meeting-planner.aspx

 

Para registrarse para el webinar, por favor ingrese en:

 

https://goo.gl/forms/3EMbRZLBfQKXf4Cj1

 

Luego de registrarse recibirá un mensaje confirmatorio con instrucciones para ingresar al webinar vía gotomeeting, y lecturas de apoyo. Esperamos contar con su participación.

 

 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn


Page 1 of 3